Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy-Reference-Cited by-同舟云学术

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

Published:2011-03-31 Issue:21 Volume:117 Page:5013-5020
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lipton Allan,Leitzel Kim,Ali Suhail M.,Carney Walter,Platek Greg,Steplewski Klaudia,Westlund Ron,Gagnon Robert,Martin Anne-Marie,Maltzman Julie

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science.,1987

3. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry;Pauletti;J Clin Oncol.,2000

4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science.,1989

5. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer;Zhou;Cancer Cell.,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients;Breast Cancer: Targets and Therapy;2024-04

2. Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging;Medical Oncology;2022-09-29

3. Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-09-20

4. Current status and future perspectives in HER2 positive advanced gastric cancer;Clinical and Translational Oncology;2022-01-29

5. Circulating Biomarkers in Breast Cancer;Clinical Breast Cancer;2021-09